Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity.

Jörg Kraus; P Oschmann; B Engelhardt; R Bauer; C Schiel; A Kern; E Stolz; A Traupe; W Dorndorf

doi:10.1034/j.1600-0404.2000.101002135.x

Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity.

Jörg Kraus^* (First author), P Oschmann, B Engelhardt, R Bauer, C Schiel, A Kern, E Stolz, A Traupe, W Dorndorf

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

13 Citations (Web of Science)

Original language	English
Pages (from-to)	135-139
Journal	ACTA NEUROLOGICA SCANDINAVICA
Volume	101
Issue number	2
DOIs	https://doi.org/10.1034/j.1600-0404.2000.101002135.x
Publication status	Published - 2000

Keywords

T-CELL
COUNTER-RECEPTOR
TNF-ALPHA
ADHESION
LFA-1
EXPRESSION
LESIONS
LYMPHOCYTES
SUBSETS
LIGAND

Access to Document

10.1034/j.1600-0404.2000.101002135.x

Cite this

Kraus, J., Oschmann, P., Engelhardt, B., Bauer, R., Schiel, C., Kern, A., Stolz, E., Traupe, A., & Dorndorf, W. (2000). Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity. ACTA NEUROLOGICA SCANDINAVICA , 101(2), 135-139. https://doi.org/10.1034/j.1600-0404.2000.101002135.x

Kraus, Jörg ; Oschmann, P ; Engelhardt, B et al. / Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity. In: ACTA NEUROLOGICA SCANDINAVICA 2000 ; Vol. 101, No. 2. pp. 135-139.

@article{0f5b8a0463364a0e9baf688da5748291,

title = "Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity.",

keywords = "T-CELL, COUNTER-RECEPTOR, TNF-ALPHA, ADHESION, LFA-1, EXPRESSION, LESIONS, LYMPHOCYTES, SUBSETS, LIGAND",

author = "J{\"o}rg Kraus and P Oschmann and B Engelhardt and R Bauer and C Schiel and A Kern and E Stolz and A Traupe and W Dorndorf",

year = "2000",

doi = "10.1034/j.1600-0404.2000.101002135.x",

language = "English",

volume = "101",

pages = "135--139",

journal = "ACTA NEUROLOGICA SCANDINAVICA ",

issn = "0001-6314",

number = "2",

}

Kraus, J, Oschmann, P, Engelhardt, B, Bauer, R, Schiel, C, Kern, A, Stolz, E, Traupe, A & Dorndorf, W 2000, 'Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity.', ACTA NEUROLOGICA SCANDINAVICA , vol. 101, no. 2, pp. 135-139. https://doi.org/10.1034/j.1600-0404.2000.101002135.x

Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity. / Kraus, Jörg (First author); Oschmann, P; Engelhardt, B et al.
In: ACTA NEUROLOGICA SCANDINAVICA , Vol. 101, No. 2, 2000, p. 135-139.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity.

AU - Kraus, Jörg

AU - Oschmann, P

AU - Engelhardt, B

AU - Bauer, R

AU - Schiel, C

AU - Kern, A

AU - Stolz, E

AU - Traupe, A

AU - Dorndorf, W

PY - 2000

Y1 - 2000

KW - T-CELL

KW - COUNTER-RECEPTOR

KW - TNF-ALPHA

KW - ADHESION

KW - LFA-1

KW - EXPRESSION

KW - LESIONS

KW - LYMPHOCYTES

KW - SUBSETS

KW - LIGAND

U2 - 10.1034/j.1600-0404.2000.101002135.x

DO - 10.1034/j.1600-0404.2000.101002135.x

M3 - Original Article

C2 - 10685862

SN - 0001-6314

VL - 101

SP - 135

EP - 139

JO - ACTA NEUROLOGICA SCANDINAVICA

JF - ACTA NEUROLOGICA SCANDINAVICA

IS - 2

ER -

Kraus J, Oschmann P, Engelhardt B, Bauer R, Schiel C, Kern A et al. Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity. ACTA NEUROLOGICA SCANDINAVICA . 2000;101(2):135-139. doi: 10.1034/j.1600-0404.2000.101002135.x